[ARTICLE WITHDRAWN] Downregulation of SRC Kinase Signaling Inhibitor 1 (SRCIN1) Expression by MicroRNA-32 Promotes Proliferation and Epithelial‐Mesenchymal Transition in Human Liver Cancer Cells

Ren Chen, Jin-Yao Liao, Jing Huang, Wen-Li Chen, Xiao-Jun Ma, Xiao-Dan Luo

Open source

DOI
10.3727/096504017x14954923820137
Published
2018-05-07
Container
Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics
Publisher
Tech Science Press
Open access
unknown

Credibility signals

serious concern Score 29/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3727/096504017x14954923820137,
  title = {[ARTICLE WITHDRAWN] Downregulation of SRC Kinase Signaling Inhibitor 1 (SRCIN1) Expression by MicroRNA-32 Promotes Proliferation and Epithelial‐Mesenchymal Transition in Human Liver Cancer Cells},
  author = {Ren Chen and Jin-Yao Liao and Jing Huang and Wen-Li Chen and Xiao-Jun Ma and Xiao-Dan Luo},
  year = {2018},
  journal = {Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics},
  doi = {10.3727/096504017x14954923820137},
  url = {https://doi.org/10.3727/096504017x14954923820137}
}

RIS

TY  - JOUR
TI  - [ARTICLE WITHDRAWN] Downregulation of SRC Kinase Signaling Inhibitor 1 (SRCIN1) Expression by MicroRNA-32 Promotes Proliferation and Epithelial‐Mesenchymal Transition in Human Liver Cancer Cells
AU  - Ren Chen
AU  - Jin-Yao Liao
AU  - Jing Huang
AU  - Wen-Li Chen
AU  - Xiao-Jun Ma
AU  - Xiao-Dan Luo
PY  - 2018
JO  - Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics
DO  - 10.3727/096504017x14954923820137
UR  - https://doi.org/10.3727/096504017x14954923820137
ER  - 

APA

Chen, R., Liao, J., Huang, J., Chen, W., Ma, X., & Luo, X. (2018). [ARTICLE WITHDRAWN] Downregulation of SRC Kinase Signaling Inhibitor 1 (SRCIN1) Expression by MicroRNA-32 Promotes Proliferation and Epithelial‐Mesenchymal Transition in Human Liver Cancer Cells. Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics. https://doi.org/10.3727/096504017x14954923820137

Source records